English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18055/20253 (89%)
造訪人次 : 25100765      線上人數 : 552
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34698


    標題: BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
    作者: Wu, Cheng-Kuei
    Wei, Man-Ting
    Wu, Hung-Chang
    Wu, Cheng-Lin
    Wu, Cheng-Ju
    Liaw, Hungjiun
    Su, Wen-Pin
    貢獻者: National Cheng Kung University
    Chi Mei Hospital
    Department of Pharmacy, Chia Nan University of Pharmacy & Science
    National Cheng Kung University
    National Cheng Kung University Hospital
    National Cheng Kung University
    National Cheng Kung University Hospital
    National Cheng Kung University
    National Cheng Kung University Hospital
    National Cheng Kung University
    關鍵字: bone morphogenetic protein-2
    breast-cancer cells
    tumor-growth
    expression
    survival
    gene
    mutations
    melanoma
    invasion
    tissue
    日期: 2022
    上傳時間: 2023-12-11 14:05:44 (UTC+8)
    出版者: NATURE PORTFOLIO
    摘要: Bone morphogenetic protein 2 (BMP2) is highly overexpressed in human non-small cell lung cancer (NSCLC) and correlates with tumor stage and metastatic burden. Although several lines of evidence suggest that BMP2 promotes cell migration and invasiveness in vitro, the in vivo role of BMP2 in the metastasis of lung adenocarcinoma cells remains less well understood. Here, we revealed that BMP2 is highly overexpressed in lung adenocarcinoma patients with lymph node metastasis compared with patients without lymph node metastasis. Using an in vivo orthotopic mouse model, we clearly demonstrated that BMP2 promotes lung adenocarcinoma metastasis. The depletion of BMP2 or its receptor BMPR2 significantly reduced cell migration and invasiveness. We further identified that BMP2/BMPR2-mediated cell migration involves the activation of the SMAD1/5/8 signaling pathway, independent of the KRAS signaling pathway. Significantly, the depletion of SMAD1/5/8 or the inhibition of SMAD1/5/8 by LDN193189 inhibitor significantly reduced cell migration. These findings show that BMP2 promotes NSCLC metastasis, indicating that targeting the BMP2 signaling pathway may represent a potential therapeutic strategy for treating patients with metastatic NSCLC.
    關聯: SCIENTIFIC REPORTS, v.12, n.16310
    顯示於類別:[藥學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML125檢視/開啟
    s41598-022-20788-2.pdf14355KbAdobe PDF83檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋